Meet with our product experts in one-on-one virtual sessions
Set Up a Meeting
With over decades of experience, Dr. Reddy's specializes in developing and manufacturing High Potent Active Pharmaceutical Ingredients (HPAPI). We offer HPAPIs manufactured in our FDA inspected cGMP API manufacturing facilities with comprehensive containment processes (up to OEL 0.1µg/m³) and diligent QC/QA.
Dr. Reddy’s Approach in Handling HPAPIs
Reddy’s approach for high-potent APIs involves the following process:
Dr. Reddy’s
Approach in
Handling
HPAPIs
01.Evaluating the hazard of exposure to a compound and calculating the OEL levels
02.Selecting the appropriate containment strategy for development and manufacturing based on scale
03.Choosing proper engineering controls such as ventilation, chemical contaminants, etc.
04.Selecting the appropriate equipment and procedures, including PPE Sampling & weighing, blending, and drying
05.Define Packaging needs to meet the requirements Capsule/Blistering Injectables
We are here to help, if you have any country specific requirements.
From initial stages of development to commercialization, our team of scientists, quality, regulatory, supply chain, and analytical experts work collaboratively to meet our global clients' HPAPI requirements.
As an integrated HPAPI supplier, we have best-in-class cGMP manufacturing facilities for APIs and finished dosage forms. With our integrated R&D capabilities and infrastructure, we are well-positioned to support our customers to bring their products to the market faster. In addition, our rigorous safety, health, and environmental (SHE) practices, together with Occupational Exposure Band (OEB) and Occupational Exposure Limit (OEL) based controls, are established to protect workers, materials, machines, and the environment.
Facilities for handling HPAPIs
Dr. Reddy’s can handle molecules of OEL up to 0.1 µg/m3 at the following facilities:
- cGMP compliant isolator systems (OEL 0.1µg/m³) for high potent raw materials, intermediates charging, filtration and drying, dispensing and packaging
- Reaction mass transfer through closed loop lines
- Rapid transfer ports for solid material transfer
- HVAC system with zone classification to avoid cross-contamination
- EPA filtered air
- Multiple utilities (cooling tower water, hot water, chilled brine, nitrogen, compressed air & steam
- Differential pressure system with temperature and humidity control
Contact Us
Please fill out the following form. We will get back to you shortly.
Related Products
Lenvatinib Mesylate (Form-C)
Anti-Cancer/ Oncology
Pazopanib
Anti-Cancer/ Oncology
Venetoclax
Anti-Cancer/ Oncology
Azacitidine
Anti-Cancer/ Oncology
Gemcitabine Hydrochloride
Anti-Cancer/ Oncology
Pomalidomide
Anti-Cancer/ Oncology
Pemetrexed Disodium Heptahydrate
Anti-Cancer/ Oncology
Palonosetron Hydrochloride
Oncology/ Anti-Emetics
Lomustine
Anti-Cancer/ Oncology
Lenalidomide (Form A)
Anti-Cancer/ Oncology
Elagolix Sodium
Pain Management
Doxazosin Mesylate
Cardiovascular
Decitabine
Anti-Cancer/ Oncology
Capecitabine
Anti-Cancer/ Oncology
Top-class safety practices and containment control strategy in place.
- HVAC system with zone classification to avoid cross-contamination
- Choosing proper engineering controls such as ventilation, chemical contaminants, etc
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。
Let’s talk API sourcing live at
Tackle sourcing bottlenecks and compliance hurdles